Department of Infectious Diseases

About Us 

The Barwon Health Department of Infectious Diseases and Infection Prevention is an academic tertiary referral program and incorporates:

  • Expert infection prevention/control service across all Barwon Health sites.
  • Infectious diseases services including consultations, inpatient care and antimicrobial stewardship to all acute care sites.
  • Accredited advanced training in infectious diseases and microbiology.
  • Specialised ambulatory and outpatient services for general infectious diseases, Hospital in the Home, HIV management, sexual and reproductive health, viral hepatitis and refugee health service with multidisciplinary models of care and pediatric input.
  • Psychiatry and pharmacy specialist liaison services and comprehensive community case management programs (HIV/HARP).
  • 24-hour community HIV post-exposure prophylaxis service.
  • Extensive infectious diseases research programs in clinical, basic sciences, public health and epidemiology.

The Department works closely with Deakin University, with many of our physicians and staff having teaching roles and academic appointments with the university. We also have close links with the GCEID, a collaborative, multidisciplinary research partnership between Deakin University, Barwon Health and the Australian Animal Health Laboratory (AAHL) and links with Alice Springs Hospital (with our registrars rotating to Central Australia for six-month placements).

The Department has active research collaborations locally and internationally, as well as running an active infectious diseases clinical trials unit.

Geelong Centre for Emerging Infectious Diseases (GCEID) in partnership with the Department of Infectious Diseases

Research program

We are a multidisciplinary research team including basic genomic and pathogen biology scientists, environmental scientists, public health specialists, epidemiologists and expert clinicians.

We are tackling diseases of public health importance including: emerging infections such Mycobacteria ulcerans (Buruli ulcer), zoonotic infections: Coxiella, Rickettsia, Biofilm infections of medical devices - orthopaedic and cardiac, and virulent pathogens like Staphylococcus aureus bloodstream infections, Endocarditis and Clostridium difficle.

Our research team and laboratory is uniquely placed across several campuses with access to patients, population cohorts, clinical samples, bio-banking and clinical trials platforms including Phase 1 through 3 studies.

Our work includes host-pathogen relationships, molecular epidemiology, disease transmission and dynamics and future preventative strategies for at-risk populations.

For further enquires contact:

Associate Professor Daniel O’Brien

Email This email address is being protected from spambots. You need JavaScript enabled to view it.

Ph 03 4215 2375

Discipline: Infection and Immunity

2020-21 highlights

Victoria experienced the drastic consequences of the second wave of COVID-19 in late 2020. Our healthcare workers across the system worked tirelessly to prepare for a large number of cases and hospitalisations but the greatest toll was on the elderly especially those in residential aged care (RACFs). Despite our careful planning, there were many deaths and rapid transmission in RACFs. In our region, we developed rapid responses, testing, outbreak management and medical escalation pathways which were tested and helped to prevent deaths.

The single most important legacy from 2020 has been the successful establishment of local Public Health Units in Victoria. At Barwon South West region (BSW) as the inaugural Director, we are building a “one-stop-shop” to manage and coordinate: rapid contact tracing, COVID monitoring, rapid testing and rollout of the new COVID vaccines across the BSW population.  In all these areas we have been at the forefront of delivering to our local population. Our contact tracing program was recognised at the Public Service Awards 2020 as a Finalist. Our vaccine rollout is leading the way in Victoria. I was awarded OAM at the Queen’s Birthday Honours for services to Infectious Disease Medicine.

Three members of our Department have been seconded to the Victorian Department of Health (DH) as Deputy Chief Health Officers (DCHOs) for varying time periods to support the statewide efforts. Dan O’Brien continues in this capacity half time and Deb Friedman has moved permanently to this role.

Our Infection prevention service continues to provide expert guidance during the complex settings of COVID ready as well as the ongoing programs to keep our patients safe from healthcare-associated infections. Our ID consultants and Registrars have worked tirelessly to help steer our health service through these challenging times and have stood up testing, contact tracing and inpatient COVID management models and provided regional expert referral support. The Aust Rickettsia Ref. lab (ARRL) has enabled our service to access rapid COVID testing with great agility and reliability.

Our programs in ID Immigrant Health, Viral hepatitis, HIV and Sexual Health continue to serve vulnerable populations effectively. We are planning a GP support partnership with the PHN and the Melb. Sexual Health Centre led by Dr Sarah Huffam and Rochelle Hamilton to improve access in our region.

We continue to support the Alice Springs Hospital with ID registrar and consultant rotations. New members of our team include Peter Gordon at BRASH, Brooke Flanders at Liver Clinic, Claire Hynes IPS and Dr Callum Maggs VMO.

Our research efforts continue to attract support with a large DJPR grant for a long-term COVID case-control study this is a multidisciplinary project with Deakin University to better understand the biological and psychological consequences of COVID infection. We are also partners with CSIRO in a new MRFF grant using cell cultures to study new potential drug targets for COVID. We have an ongoing partnership with the University of Melb. for a new NHMRC grant to extend our Controlling Buruli Ulcer project.

Dr Amanda Wade is leading a successful program in partnership with the Burnet Institute to test and treat high-risk patients for hepatitis C infection. At the School of Medicine, Darcie Cooper successfully completed her PhD in Prosthetic joint infections and Carly Botheras has submitted her PhD in Staph. aureus bloodstream infections. The Clinical Trials team, despite the COVID restrictions, have successfully set up and undertaken several new studies including 3 phase 1-2 in Novovax vaccines, RSV vaccines in adults and Pregnancy and a new Staph Vaccine.

 Key publications

 

  1. The impact of infectious diseases consultation on the management and outcomes of Pseudomonas aeruginosa bacteremia in adults: a retrospective cohort study. Chiong F, Wasef MS, Liew KC, Cowan R, Tsai D, Lee YP, Croft L, Harris O, Gwini SM, Athan E. BMC Infect Dis. 2021 Jul 9;21(1):671.
  2. Pregnancy - a key moment for engaging women with hepatitis B in care. Roder C, Chand S, Streat S, Beynon S, Huning E, Dabkowski P, Athan E, Wade AJ. Aust N Z J Public Health. 2021 Jun;45(3):299-300.
  3. C-reactive protein predicts complications in community-associated S. aureus bacteremia: a cohort study. Botheras CL, Bowe SJ, Cowan R, Athan E. BMC Infect Dis. 2021 Apr 1;21(1):312.
  4. The effectiveness of a simple antimicrobial stewardship intervention in general practice in Australia: a pilot study. Neels AJ, Bloch AE, Gwini SM, Athan E.BMC Infect Dis. 2020 Aug 7;20(1):586.

Meet the team

Director

 Daniel O Brien Web 1058276

Associate Professor Daniel O’Brien, MBBS, FRACP (Infec Dis), DMedSc, Dip Anat

Interests: Mycobacterial infections including M. ulcerans, TB and leprosy, HIV, Viral hepatitis, Refugee health and Travel medicine

Infectious Diseases Consultants

ID website Andrew Hughes

Associate Professor Andrew Hughes, MBBS, FRACP (Infec Dis)

Interests: General medicine, HIV, M. ulcerans infection

 

Eugene Athan            

Professor Eugene Athan, MBBS, FRACP (Infec Dis), MPH , MD

Interests: Healthcare-associated infections including prosthetic joint infection, Infective endocarditis, HIV, Clostridium difficile infection, Clinical trials 

ID website Amanda wade

Dr Amanda Wade (Ph.D.), MBBS (Hons) FRACP (Infec Dis),

Interests: Viral hepatitis, HIV, Public Health.

 

ID website Sarah huffam

Dr Sarah Huffam, MBBS, MPH&TM, FAChSHM, FRACP (Infec Dis)

Interests: Sexual health, Viral hepatitis, HIV, Prosthetic joint infection

  

dr.jpg

Dr Nomvuyo Mothobi
BBiomedSc MBBS MIPH FRACP FRCPA

Interests: HIV, infections in transplant recipients, molecular diagnostic methods, microbial genomics

ID website Aaron walton

Dr Aaron Walton, MD, FRACP (Infec Dis), FRCPA

Interests: Clinical microbiology, General medicine 

ID website Cameron Jeremiah

Dr Cameron Jeremiah MBBS, FRACP

Interests: prosthetic joint infections, General Medicine

ID website Caroline Bartolo

Dr Caroline Bartolo, MD, FRACP

Interests: infection prevention, healthcare-associated infections, clinical teaching, public health, antimicrobial stewardship program

callum

Dr Callum Maggs, BSC, ID, PHD, Medical Lead Vaccination, General Medicine

Interests: general Infectious Diseases, host immunity, prosthetic devise infections, immunisation & antibiotic allergies

Clinical Microbiologists (Australian Clinical Labs, Geelong)

dr.jpg

Infectious Diseases Physician & Microbiologist

Dr Nomvuyo Mothobi
BBiomedSc MBBS MIPH FRACP FRCPA

Interests: HIV, infections in transplant recipients, molecular diagnostic methods, microbial genomics

ID website Aaron walton

Infectious Diseases Physician & Microbiologist

Dr Aaron Walton, MD, FRACP (Infec Dis), FRCPA

Interests: Clinical microbiology, General medicine 

Infectious Diseases registrars

Shaun Inthavong Dr Shaun Inthavong
Joanne Peel Dr Joanne Peel
Generic

Dr Christine Wade
Lani DeSilva

Dr Lani De Silva

Clinical nurse consultant and manager for BRASH (Barwon Reproductive and Sexual Health) clinic

ID website Rochelle Hamilton

Ms Rochelle Hamilton, RN; Reg Midwife; Family Planning Cert 1 & 2; Accred PapTest Provider; Grad Dip Community Health Nursing; Masters Health Science (Sexual Health); Accred HIV/HepC Counsellor; Cert in Counselling HIV/AIDS (Family Therapy) Bouverie Centre; Cert IV Workplace Training & Assessment; Cert in Leadership Management & Development; Clinical Tutor Deakin Medical School (postgraduate program)

HARP (HIV) clinicians for BRASH clinic

ID website Helen Fay

Ms Helen Fay, RN, Grad Dip Palliative Care, Acc HIV & HCV pre-/post testing

ID website Cico

Mr Cico Lobbert, Bachelor of Social Work

Sexual Health Physicians

Generic

Dr Heidi Zoumboulakis MBBS, FRACGP
SArah Huffum Dr Sarah Huffum 

ID website Michael Roberts

Dr Michael Roberts MBBS, DRACOG, DGUM

 

Antimicrobial stewardship pharmacist

ID website Alicia Neels

Ms Alicia Neels, B.Pharm (Hons) GradCertPharmPrac

Generic

Ms Janice Chiang, B. Pharm

HIV pharmacist

Generic

Ms Kate Mackie, BPharm, GradDipClinPharm, BCGP

HIV Liaison Psychiatrist

Generic

Dr Emma Nicholson

Hepatology Nurse Consultants

Brooke Flanders                   Liver Clinic Coordinator

Susan Streat                          Liver Clinic and Liver Mass Clinic RN

Inga Tribe                              Viral Hepatitis Outreach CNC, Barwon & South West Victoria

Leave Cover CNC’s               Kirsty McColl and Peggy Austin

Generic

Ms Margaret Wardrop RN, BN, Cert Sterilisation & Inf Cont, Acc HIV & HCV Counsellor, Reg Sick Children’s Nurse (UK), Cert IV Workplace Assessment & Training

Generic

Ms Susan Streat, RN, Certificate of family planning, BA. Certificate of Midwifery   

Generic

Ms Inga Tribe, RN

Liver Clinic Research Assistant

Generic

Dr Christine Roder PhD

Infection Prevention Service

Alison mckenzie

Ms Alison McKenzie, RN, BN, Grad Cert in Nursing Science (Infection Control), Acc HIV Counsellor, Nurse Immuniser, Cert IV in training and Assessment, Cert IV in Frontline Business Management
Dr Caroline Bartolo Dr Caroline Bartolo, IPS Clinical Lead 

Leonie

Leonie Irwin RMD Co-Ordinator
  • Kelly Williams, RN, BN, Grad Cert in Nursing Science (Infection Control)
  • Claire Hynes RN, BN, Grad Dip of Critical Care( Intensive Care), Grad Cert in Nursing Science( Infection Control)
  • Mary Butters RN, Grad Cert Public Health, Nurse Immuniser, Cert IV training & Assessment

Clinical nurse consultants

Generic

Ms Penny Radalji, RN, Cert of Intensive Care, Grad Dip Critical Care Nursing, Graduate Certificate in Infection Control Nursing

ID website Ann gray

Ms Ann Gray, RN, Cert Sterilisation & Inf Control, Nurse Immuniser, Acc HIV Counsellor, Cert IV Training & Assessment, Adv Dip Business Management, Adv Dip Human Resources Management

Generic

Ms Julie Heath, MPH, Credentialed Infection Prevention Practitioner (CICP)  RN, BN, Gazetted Mediator DSCV, Cert S& IC, Cert of Intensive Care, Grad.Dip in Public Health, Cert IV Workplace Assessment & Training

Kelly Williams

Ms Kelly Williams, RN, BN
CLAIRE

Claire Hynes
lOUISE

Louise Laurie
MAry

Mary Butters

Infection Surveillance and Audit Nurse

Gephanee

Gephanee Tadifa

Clinical Trials Unit

ID website Bree Sarah

Bree Sarah, BSc (Hons), Advanced Dip of Management, ACRP Certified Clinical Research Coordinator, Advanced Dip of Management

ID website Kate Ellis

Kate Ellis, BN Div 1 RN

Generic

Fahriya Zandari, BN Div 1 RN

Administrative Support

mandy ryan

Mandy Ryan

Administration Assistant to Infectious Diseases director  

Infectious Diseases/Immigrant/Refugee Health Clinic

Human Resources

  • Prof Eugene Athan
  • A/Prof. Dr Daniel O’Brien
  • A/Prof. Dr Deb Friedman
  • Dr Aaron Walton
  • Dr Cameron Jeremiah
  • Dr Sarah Huffam
  • Dr Andrew Hughes
  • Dr Caroline Bartolo
  • Dr Callum Maggs

  • pediatric Consultants

  • Dr Kate McCloskey
  • Dr Jane Standish
  • Dr Margy Fulton

Clinic Coordinator

Jude Butwilowsky

Liver Clinic

Human Resources

Amanda Wade

Amanda Wade, Director

Research Assistant

Christine Roder

Gastroenterologists

  • Dr Damien Dowling
  • Dr Sumaya Alukaidey
  • Dr Mohammed Al-Ansari
  • Dr Sam Hall

Respiratory Protection Program
Generic

Nurhanie Tulawie
Generic

Amy Banks
Generic

Angela McAninley
Generic

Praveen Petrack

Our Research

Publications (select a year)

2020-21

Peer-reviewed publications for 2020-2021

  1. The impact of infectious diseases consultation on the management and outcomes of Pseudomonas aeruginosa bacteraemia in adults: a retrospective cohort study. Chiong F, Wasef MS, Liew KC, Cowan R, Tsai D, Lee YP, Croft L, Harris O, Gwini SM, Athan E. BMC Infect Dis. 2021 Jul 9;21(1):671. doi: 10.1186/s12879-021-06372-5. PMID: 34243714 Free PMC article.
  2. Pediatric Staphylococcus aureus bacteremia: clinical spectrum and predictors of poor outcome. Campbell AJ, Al Yazidi LS, Phuong LK, Leung C, Best EJ, Webb RH, Voss L, Athan E, Britton PN, Bryant PA, Butters CT, Carapetis JR, Ching NS, Coombs GW, Daley D, Francis J, Hung TY, Mowlaboccus S, Nourse C, Ojaimi S, Tai A, Vasilunas N, McMullan B, Blyth CC, Bowen AC.Clin Infect Dis. 2021 Jun 5:ciab510. doi: 10.1093/cid/ciab510. Online ahead of print. PMID: 34089594.
  3. The cytokine storms of COVID-19, H1N1 influenza, CRS and MAS compared. Can one-sized treatment fit all? Morris G, Bortolasci CC, Puri BK, Marx W, O'Neil A, Athan E, Walder K, Berk M, Olive L, Carvalho AF, Maes M. Cytokine. 2021 Aug;144:155593. doi: 10.1016/j.cyto.2021.155593. Epub 2021 May 26. PMID: 34074585 Free PMC article. Review.
  4. Pregnancy - a key moment for engaging women with hepatitis B in care. Roder C, Chand S, Streat S, Beynon S, Huning E, Dabkowski P, Athan E, Wade AJ. Aust N Z J Public Health. 2021 Jun;45(3):299-300. doi: 10.1111/1753-6405.13109. Epub 2021 Apr 26. PMID: 33900664 No abstract available.
  5. Infective Endocarditis in Patients on Chronic Hemodialysis.

Pericàs JM, Llopis J, Jiménez-Exposito MJ, Kourany WM, Almirante B, Carosi G, Durante-Mangoni E, Fortes CQ, Giannitsioti E, Lerakis S, Montagna-Mella R, Ambrosioni J, Tan RS, Mestres CA, Wray D, Pachirat O, Moreno A, Chu VH, de Lazzari E, Fowler VG Jr, Miró JM; ICE Investigators.

J Am Coll Cardiol. 2021 Apr 6;77(13):1629-1640. doi: 10.1016/j.jacc.2021.02.014. PMID: 33795037

  1. C-reactive protein predicts complications in community-associated S. aureus bacteraemia: a cohort study. Botheras CL, Bowe SJ, Cowan R, Athan E, BMC Infect Dis. 2021 Apr 1;21(1):312. doi: 10.1186/s12879-021-05962-7. PMID: 33794783 Free PMC article.
  2. Bittersweet: infective complications of drug-induced glycosuria in patients with diabetes mellitus on SGLT2-inhibitors: two case reports. Bartolo C, Hall V, Friedman ND, Lanyon C, Fuller A, Morrissey CO, Athan E. BMC Infect Dis. 2021 Mar 20;21(1):284. doi: 10.1186/s12879-021-05982-PMID: 33743624 Free PMC article.
  3. Prospective Cohort Study of Infective Endocarditis in People Who Inject Drugs.

Pericàs JM, Llopis J, Athan E, Hernández-Meneses M, Hannan MM, Murdoch DR, Kanafani Z, Freiberger T, Strahilevitz J, Fernández-Hidalgo N, Lamas C, Durante-Mangoni E, Tattevin P, Nacinovich F, Chu VH, Miró JM; International Collaboration on Endocarditis (ICE) Investigators.

J Am Coll Cardiol. 2021 Feb 9;77(5):544-555. doi: 10.1016/j.jacc.2020.11.062.

PMID: 33538252

  1. Efficacy and safety of fecal microbiota transplantation for the treatment of diseases other than Clostridium difficile infection: a systematic review and meta-analysis.

Green JE, Davis JA, Berk M, Hair C, Loughman A, Castle D, Athan E, Nierenberg AA, Cryan JF, Jacka F, Marx W. Gut Microbes. 2020 Nov 9;12(1):1-25. doi: 10.1080/19490976.2020.1854640.

PMID: 33345703 Free PMC article.

  1. Association between minimum inhibitory concentration, beta-lactamase genes and mortality for patients treated with piperacillin/tazobactam or meropenem from the MERINO study.

Henderson A, Paterson DL, Chatfield MD, Tambyah PA, Lye DC, De PP, Lin RTP, Chew KL, Yin M, Lee TH, Yilmaz M, Cakmak R, Alenazi TH, Arabi YM, Falcone M, Bassetti M, Righi E, Ba R, Kanj SS, Bhally

H, Iredell J, Mendelson M, Boyles TH, Looke DFM, Runnegar NJ, Miyakis S, Walls G, Ai Khamis M, Zikri A, Crowe A, Ingram PR, Daneman NN, Griffin P, Athan E, Roberts L, Beatson SA, Peleg AY, Cottrell KK, Bauer MJ, Tan E, Chaw K, Nimmo GR, Harris-Brown T, Harris PNA; MERINO Trial Investigators and the Australasian Society for Infectious Disease Clinical Research Network (ASID-CRN).

Clin Infect Dis. 2020 Oct 27:ciaa1479. doi: 10.1093/cid/ciaa1479. Online ahead of print.

PMID: 33106863

  1. Preventing the development of severe COVID-19 by modifying immunothrombosis.

Morris G, Bortolasci CC, Puri BK, Olive L, Marx W, O'Neil A, Athan E, Carvalho A, Maes M, Walder K, Berk M.

Life Sci. 2021 Jan 1;264:118617. doi: 10.1016/j.lfs.2020.118617. Epub 2020 Oct 20.

PMID: 33096114 Free PMC article. Review.

  1. Can endolysosomal deacidification and inhibition of autophagy prevent severe COVID-19?

Morris G, Athan E, Walder K, Bortolasci CC, O'Neil A, Marx W, Berk M, Carvalho AF, Maes M, Puri BK.

Life Sci. 2020 Dec 1;262:118541. doi: 10.1016/j.lfs.2020.118541. Epub 2020 Oct 6.

PMID: 33035581 Free PMC article. Review.

  1. The effectiveness of a simple antimicrobial stewardship intervention in general practice in Australia: a pilot study.

Neels AJ, Bloch AE, Gwini SM, Athan E.

BMC Infect Dis. 2020 Aug 7;20(1):586. doi: 10.1186/s12879-020-05309-8.

PMID: 32767968 Free PMC article.

  1. The pathophysiology of SARS-CoV-2: A suggested model and therapeutic approach.

Morris G, Bortolasci CC, Puri BK, Olive L, Marx W, O'Neil A, Athan E, Carvalho AF, Maes M, Walder K, Berk M.

Life Sci. 2020 Oct 1;258:118166. doi: 10.1016/j.lfs.2020.118166. Epub 2020 Jul 31.

PMID: 32739471 Free PMC article. Review.

  1. Risk Factors Associated with Antibiotic Treatment Failure of Buruli Ulcer.

O'Brien DP, Friedman ND, Walton A, Hughes A, Athan E.

Antimicrob Agents Chemother. 2020 Aug 20;64(9):e00722-20. doi: 10.1128/AAC.00722-20. Print 2020 Aug 20.

  1. In Vitro Investigation of Auranofin as a Treatment for Clostridium difficile Infection.

Roder C, Athan E.

Drugs R D. 2020 Sep;20(3):209-216. doi: 10.1007/s40268-020-00306-3.

PMID: 32377889 Free PMC article.

  1. Necrotising enterocolitis caused by Clostridium perfringens: a life-threatening manifestation of a common foodborne infection.

Walker HN, Liew KC, Adams V, Larcombe S, Nagra SS, Guest G, Athan E.

Med J Aust. 2020 Aug;213(3):114-115.e1. doi: 10.5694/mja2.50568. Epub 2020 Apr 2.

PMID: 32239699 No abstract available.

  1. Cost and Outcomes of Implantable Cardiac Electronic Device Infections in Victoria, Australia.

Roder C, Gunjaca V, Otome O, Gwini SM, Athan E.

Heart Lung Circ. 2020 Jul;29(7):e140-e146. doi: 10.1016/j.hlc.2019.10.010. Epub 2019 Nov 27.

PMID: 31839364

  1. Wade AJ, Doyle JS, Draper B, Howell J, Iser D, Roberts SK, Kemp W, Thompson AJ, Hellard ME, In support of community-based hepatitis C treatment with triage of people at risk of cirrhosis to specialist care, JVH, 2021 Jan;28(1):217-218.
  2. Christine Roder, Paul Nguyen, Craig Harvey, Margaret Wardrop, Jane Finlay, Lekan Ogunleye, Harry Hill, Eugene Athan, Amanda J. Wade, Psychiatrists can treat hepatitis C, JVH, submitted, August 2021.
  3. Harney BL, Whitton B, Read J, Lim C, Paige E, McDonald B, Nolan S, Brereton R, Weiss R, Membrey D, Samuel-King J, Wade AJ, Iser D, Thompson A, Roberts SK, Spelman T, Sacks-Davis R, Hellard ME, Doyle JS, A multi-site, nurse-coordinated hepatitis C model of care in primary care and community services in Melbourne, Australia, CID, submitted, August 2021.
  4. Christine Roder, Callum Maggs, Bridgette J McNamara, Daniel P O’Brien, Amanda J Wade, Catherine M Bennett, Julie A Pasco, Eugene Athan, Social Determinants of COVID-19 transmission during the Second Wave in Victoria, Australia, MJA, In press 2021.
  5. Bart J Currie, Mark Mayo, Linda M Ward, Mirjam Kaestli, Ella M Meumann, Jessica R Webb, Celeste Woerle, Robert W Baird, Ric N Price, Catherine S Marshall, Anna P Ralph, Emma Spencer, Jane Davies, Sarah E Huffam, Sonja Janson, Sarah Lynar, Peter Markey, Vicki L Krause, Nicholas M Anstey. The Darwin Prospective Melioidosis Study: a 30-year prospective, observational investigation. Lancet Infect Dis. Published online July 22, 2021 
  6. Trends and outcomes of Enterobacterale bloodstream infections in cancer patients: review in a large regional centre. Parry LA, Kha T, Gwini S-M, Athan E, Cowan R. In preparation
  7. Impact of time to first antimicrobial dose on length of stay and 30-day hospital readmission in patients with lower limb cellulitis. Bishop JL, Jones M, Farquharson J, Summerhayes K, Tucker R, Smith M, Cowan R, Friedman ND, Schulz TR, Kong DCM, Buising KL.J Glob Antimicrob Resist. 2021 Jun;25:367-369. doi: 10.1016/j.jgar.2021.04.007. Epub 2021 May 12.PMID: 33991747
  8. Planning and clinical role of acute medical home care services for COVID-19: consensus position statement by the Hospital-in-the-Home Society Australasia. Bryant PA, Rogers BA, Cowan R, Bowen AC, Pollard J; Hospital-in-the-Home Society Australasia. Intern Med J. 2020 Oct;50(10):1267-1271. doi: 10.1111/imj.15011. Epub 2020 Sep 18.PMID: 32945570
  1. Planning and clinical role of acute medical home care services for COVID-19: consensus position statement by the Hospital-in-the-Home Society Australasia. Bryant PA, Rogers BA, Cowan R, Bowen AC, Pollard J; Hospital-in-the-Home Society Australasia. Intern Med J. 2020 Oct;50(10):1267-1271. doi: 10.1111/imj.15011. Epub 2020 Sep 18.PMID: 32945570 

 

2019

  1. Simethicone use during gastrointestinal endoscopy: Position statement of the Gastroenterological Society of Australia.
    Devereaux BM, Taylor ACF, Athan E, Wallis DJ, Brown RR, Greig SM, Bailey FK, Vickery K, Wardle E, Jones DM. J Gastroenterol Hepatol. 2019 Jun 26. doi: 10.1111/jgh.14757. [Epub ahead of print] Review.
    PMID: 31242327 [PubMed - as supplied by publisher]
    Similar articles

  1. Six versus eight weeks of antibiotics for small Mycobacteriumulcerans lesions in Australian Patients.
    O'Brien DP, Friedman ND, Cowan R, Walton A, Athan E. Clin Infect Dis. 2019 Jun 20. pii: ciz532. doi: 10.1093/cid/ciz532. [Epub ahead of print]
    PMID: 31231766 [PubMed - as supplied by publisher]
    Similar articles

  2. Enterococcal bacteraemia "Silent but deadly": a population-based cohort study.
    Cabiltes I, Coghill S, Bowe SJ, Athan E.
    Intern Med J. 2019 Jun 10. doi: 10.1111/imj.14396. [Epub ahead of print]
    PMID: 31180166 [PubMed - as supplied by publisher]
    Similar articles

  1. Corrigendum to "association between the timing of surgery for complicated, left-sided infective endocarditis and survival", American HeartJournal 2019, volume 210, April 2019, pages 108-116.
    Wang A, Chu VH, Athan E, Delahaye F, Freiberger T, Lamas C, Miro JM, Strahilevitz J, Tribouilloy C, Durante-Mangoni E, Pericas JM, Fernández-Hidalgo N, Nacinovich F, Barsic B, Giannitsioti E, Hurley JP, Hannan MM, Park LP; ICE-PLUS Investigators.Am Heart J. 2019 Jun;212:165. doi: 10.1016/j.ahj.2019.03.006. Epub 2019 Apr 16. abstract available.
    PMID: 31003633 [PubMed]
    Similar articles

  1. The association between vegetation size and surgical treatment on 6-month mortality in left-sided infective endocarditis.
    Fosbøl EL, Park LP, Chu VH, Athan E, Delahaye F, Freiberger T, Lamas C, Miro JM, Strahilevitz J, Tribouilloy C, Durante-Mangoni E, Pericas JM, Fernández-Hidalgo N, Nacinovich F, Rizk H, Barsic B, Giannitsioti E, Hurley JP, Hannan MM, Wang A; ICE-PLUS Investigators.
    Eur Heart J. 2019 Apr 12. pii: ehz204. doi: 10.1093/eurheartj/ehz204. [Epub ahead of print]
    PMID: 30977784 [PubMed - as supplied by publisher]
    Similar article

  1. Faecal microbiota transplants for depression - Who gives a crapsule?
    Green J, Castle D, Berk M, Hair C, Loughman A, Cryan J, Nierenberg A, Athan E, Jacka F. Aust N Z J Psychiatry. 2019 Apr 8:4867419839776. doi: 10.1177/0004867419839776. [Epub ahead of print] No abstract available.
    PMID: 30957511 [PubMed - as supplied by publisher]
    Similar articles

  1. Association between the timing of surgery for complicated, left-sided infective endocarditis and survival.
    Wang A, Chu VH, Athan E., Delahaye F, Freiberger T, Lamas C, Miro JM, Strahilevitz J, Tribouilloy C, Durante-Mangoni E, Pericas JM, Fernández-Hidalgo N, Nacinovich F, Barsic  B, Giannitsioti E, Hurley JP, Hannan MM, Park LP; ICE-PLUS Investigators.
    AM Heart J. 2019  Apr;210:108-116. doi: 10.1016/j.ahj.2019.01.004. Epub 2019 Jan 17.Erratum in: Am Heart J. 2019 Jun;212:165.
    PMID: 30802708 [PubMed - in process]
    Similar articles

  1. Spontaneous healing of Mycobacterium ulcerans disease in Australian Patients.
    O’Brien DP, Murrie A, Meggyesy P, Priestley J, Rajcoomar A, Athan E.  
    PLos Negl Trop Dis 2019 Feb 19; 13(2):e0007178. doi: 10.1371/journal.pntd.0007178.
    eCollection 2019 Feb.
    PMID:  30779807 [PubMed - indexed for MEDLINE] Free PMC Article
    Similar Articles 

  1. Silent but deadly: patients with enterococcal bacteraemia should be assessed for colorectal neoplasia.
    Athan E., Cabiltes I, Coghill S, Bowe SJ.
    Med J Aust. 2019 Feb; 210(2):86. doi: 10.5694/mja2.12027. Epub 2018 Nov 7. No abstract available
    PMID: 30712310 [PubMed - in process]
    Similar Articles

  1. Fosfomycin:what was old is new again.
    Avent ML, Rogers BA, Cheng AC, Athan E, Francis JR, Roberts MJ, Paterson DL, Harris PNA
    Intern Med J. 2018 Dec; 48(12): 1425-1429.  doi: 10.1111/imj.14122.  No abstract available.
    PMID: 30517987 [PubMed – indexed for MEDLINE]
    Similar articles

  1. Australian infection control in endoscopy consensus statements on carbapenemase-producing Enterobacteriaceae.
    Devereaux BM, Athan E, Brown  RR, Greig SM, Jones  DM, Bailey FK, Wallis DJ Singh R., J Gastroenterol Hepatol. 2019 Apr;34(4):650-658. doi: 10.1111/jgh.14511. Epub 2018 Nov 21.
    PMID: 30345549 [PubMed - indexed for MEDLINE]
    Similar articles

  1. Kidey Health Australia – Caring for Australians with Renal Impairment guideline recommendations for infection control for haemodialysis units.
    Jardine M, Commons RJ, de Zoysa JR, Wong MG, Gilroy N, Green J, Henderson B, Stuart RL, Tunnicliffe DJ, van Eps C, Athan E., Nephrology  (Carlton). 2018  Oct 16. doi: 10.1111/nep.13511. [Epub ahead of print]
    PMID: 30328179[PubMed – as supplied by publisher]
    Similar articles

  1. The changing epidemiology worldwide of Mycobacterium ulcerans.
    O’Brien DP, Jeanne I, Balsdell K, Avumegah M, Athan E., Epidemiol Infect. 2018 Oct 8:1-8. doi: 10.1017/S0950268818002662. [Epub ahead of  print]
    PMID: 30293536 [PubMed - as supplied by publisher] Free PMC Article
    Similar articles

  1. Mycrobacterium ulcerans disease management in Australian patients: The re-emergence of surgery as an important treatment modality.
    O’Brien DP, Callan P, Friedman ND, Athan E, Hughes A, McDonald A., ANZ J Surg. 2019 Jun; 89(6):653-658. doi: 10.1111/ans.14829. Epub 2018 Sep 21 Review.
    PMID: 30239097 [PubMed - in process]
    Similar Articles

  1. Effect of Piperacillin - Tazobactam vs Meropenem on 30-Day Mortality for Patient with E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial.
    Harris PNA, Tambyah  PA, Lye DC, Mo Y, Lee TH, Yilmaz M,  Alenazi TH, Arabi Y, Falcone M, Bassetti M, Righi E, Rogers BA, Kanj S, Bhally H, Iredell J, Mendelson M, Boyles TH, Looke  D, Miyakis S, Walls  G, Al  Khamis M, Zikri A, Crowe  A, Ingram P, Daneman N, Griffin P, Athan E, Lorenc P, Baker P, Roberts L, Beatson  SA, Peleg AY,   Harris-Brown T, Paterson  DL; MERINO  Trial Investigators and the Australasian  Society for Infectious Disease Clinical Research Network (ASID-CRN).
    JAMA. 2018 Sep 11;320(10):984-994. doi: 10.1001/jama.2018.12163. Erratum in: JAMA. 2019 Jun 18;321(23):2370.
    PMID: 30208454 [PubMed - indexed for MEDLINE] Free PMC Article
    Similar articles 

  1. Low incidence of recurrent Buruli ulcers in treated Australian patients living in an endemic region.
    Wynne JW, Stinear TP, Athan E., Michalski WP, O'Brien DP., PLoS Negl Trop Dis. 2018 Aug 13;12(8):e0006724. doi:  10.1371/journal.pntd.0006724. eCollection 2018 Aug
    PMID: 30102695 [PubMed - indexed for MEDLINE] Free PMC Article
    Similar articles 

  1. Bilateral osteomyelitis and liver abscess caused by hypervirulent Klebsiella pneumonia-a rare clinical manifestation (case report).
    Sturm E, Tai A, Lin B, Kwong J, Athan E.,  Howden BP, Angliss RD, Asaid R, Pollard J., BMC Infect Dis. 2018 Aug 7;18(1):380. doi: 10.1186/s12879-018-3277-4.
    PMID: 300876713 [PubMed - indexed for MEDLINE] Free PMC Article
    Similar articles 

  1. Quality of Life impact of Recombinant Zoster Vaccine in adults≥50 Years of Age.
    Curran D, Oostvogels L, Heineman T, Matthews S, McElhaney J, McNeil S, Diez- Domingo J, Lal H, Andrews C, Athan E.,  Berglund J, Campora L, de Looze F, Korhonen, T, Leung E, Levin M, Volpi A, Johnson RW; ZOE-50/70 study group. J Gerontol A Biol. Sci Med Sci. 2018 Jun 27. Doi: 10.1093/gerona/gly150. [Epub ahead of  print]
    PMID: 29955836 [PubMed - as supplied by publisher] Free PMC Article
    Similar Articles

  1. Aiming for elimination: Outcomes of a consultation pathway supporting regional general practitioners to prescribe direct-acting anttivira; therapy for hepatitis C.
    Wade AJ, McCormack A, Roder C, McDonald K, Davies M, Scott N, Wardrop M, Athan E, Hellard ME., J Viral Hepat. 2018 Sep;25(9):1089-1098. doi: 10.1111/jvh.12910. Epub 2018 May 8.
    PMID: 29660212 [PubMed - indexed for MEDLINE]
    Similar articles  

  1. Scrub typhus diagnosis on acute specimens using serological and molecular assays-prospective study.
    Koralur M, Singh R, Varma M, Shenoy S, Acharya V, Kamath A, Stenos J, Athan E, Bairy I.  Diagn Microbiol Infect Dis. 2018 Jun;91(2):112-117. doi: 10.1016/j.diagmicrobio.2018.01.018. Epub  2018 Feb 24.
    PMID: 29706479 [PubMed - indexed for MEDLINE]
    Similar articles

  1. Optimizing treatment of respiratory tract infections in nursing homes: nurse-initiated PCR testing. Am J Infect Control 2019; in press.
    Dowson L, Buising KL, Kong C, Friedman ND, Kong DCM, Stuart RL.

  1. Junior doctor training: Has the pendulum swung too far?
    Friedman ND.
    Int Med Journal 2019; in press.

  1. Six versus eight weeks of antibiotics for small Mycobacterium ulcerans lesions in Australian Patients.
    O’Brien DP, Friedman ND, Cowan RU, Walton AL, Athan E.
    Clin Infect Dis 2019; in press.

  1. Mycobacterium ulcerans disease management in Australian patients: the re-emergence of surgery as an important treatment modality.
    O'Brien DP, Callan P, Friedman ND, Athan E, Hughes A, McDonald A.
    ANZ J Surg 2018; doi: 10.1111/ans.14829.

  1. Lessons learned from a randomised controlled trial of short course intravenous antibiotic therapy for erysipelas and cellulitis of the lower limb (SWITCH Trial).
    Clarke MC, Cheng AC, Pollard JGD, Birch M, Cowan RU, Linke JA, Walton AL, Friedman ND.
    Open Forum Inf Dis 2019; in press.

  1. Six versus eight weeks of antibiotics for small Mycobacteriumulcerans lesions in Australian Patients.
    O'Brien DP, Friedman ND, Cowan R, Walton A, Athan E. Clin Infect Dis. 2019 Jun 20. pii: ciz532. doi: 10.1093/cid/ciz532.

  1. Diagnosis of Mycobacterium ulcerans disease: be alert to the possibility of negative initial PCR results.
    O'Brien DP, Globan M, Fyfe JM, Lavender CJ, Murrie A, Flanagan D, Meggyesy P, Priestley JT, Leslie D. Med J Aust. 2019 Feb 25. doi: 10.5694/mja2.50046.

  1. Spontaneous healing of Mycobacterium ulcerans disease in Australian patients.
    O'Brien DP, Murrie A, Meggyesy P, Priestley J, Rajcoomar A, Athan E. PLoS Negl Trop Dis. 2019 Feb 19;13(2):e0007178. doi: 10.1371/journal.pntd.0007178. eCollection 2019 Feb.

  1. Female Genital Schistosomiasis and HIV: Research urgently needed to improve understanding of the health impacts of this important co-infection.
    O'Brien DP, Ford N, Djirmay AG, Calmy A, Vitoria M, Jensen TO, Christinet V. J Acquir Immune Defic Syndr. 2019 Jan 25. doi: 10.1097/QAI.0000000000001957.

  1. The changing epidemiology worldwide of Mycobacterium ulcerans.
    O'Brien DP    , Jeanne I, Blasdell K, Avumegah M, Athan E. Epidemiol Infect. 2018; 147: e19, 1–8.
    https://doi.org/10.1017/S0950268818002662

  1. Mycobacterium ulcerans disease management in Australian patients: the re-emergence of surgery as an important treatment modality.
    O'Brien DP, Callan P, Friedman ND, Athan E, Hughes A, McDonald A. ANZ J Surg. 2018 Sep 21. doi: 10.1111/ans.14829.

  1. The association of rainfall and Buruli ulcer in southeastern Australia.
    Yerramilli A, Tay EL, Stewardson AJ, Fyfe J, O'Brien DP, Johnson PDR. PLoS Negl Trop Dis. 2018 Sep 17;12(9):e0006757. doi: 10.1371/journal.pntd.0006757.

  1. Low incidence of recurrent Buruli ulcers in treated Australian patients living in an endemic region.
    Wynne JW, Stinear TP, Athan E, Michalski WP, O'Brien DP. PLoS Negl Trop Dis. 2018 Aug 13;12(8):e0006724. doi: 10.1371/journal.pntd.0006724. eCollection 2018 Aug

  1. Provision and continuation of antiretroviral therapy during acute conflict: the experience of MSF in Central African Republic and Yemen.
    Ferreyra C, O’Brien DP, Alonso B , Al-Zomour A, Ford N. Conflict and Health (2018) 12:30
    https://doi.org/10.1186/s13031-018-0161-1

  1. Tackling the worsening epidemic of Buruli ulcer in Australia in an information void: time for an urgent scientific response.
    O'Brien DP, Athan E, Blasdell K, De Barro P. Med J Aust. 2018 Apr 16;208(7):287-289.

  1. Ibrutinib and antimicrobial therapy in a heavily pretreated patient with chronic lymphocytic leukemia and disseminated cutaneous non-tuberculous mycrobacterial infection: successful surgery-free approach.
    Maddy LE, O'Brien DP, Campbell PJ. Intern Med J. 2018 Apr;48(4):477-479. doi: 10.1111/imj.13756. 

  1. Wound healing: Natural history and risk factors for delay in Australian patients treated with antibiotics for Mycobacterium ulcerans disease.
    O'Brien DP, Friedman ND, McDonald A, Callan P, Hughes A, Walton A, Athan E. PLoS Negl Trop Dis. 2018 Mar 19;12(3):e0006357. doi: 10.1371/journal.pntd.0006357.

  1. Increased Severity and Spread of Mycobacterium ulcerans, Southeastern Australia.
    Tai AYC, Athan E, Friedman ND, Hughes A, Walton A, O'Brien DP. Emerg Infect Dis. 2018; 24(1):58-64. doi: 10.3201/eid2401.171070.

  1. Changes in general practitioners’ hepatitis C knowledge and management two years after direct-acting antiviral therapy became available,
    Gooey, Michelle; Wong , Evelyn; Pedrana, Alisa; Allard, Nicole; Doyle, Joseph; Hellard, Margaret; Wade, Amanda,  
    ANZPH, submitted August 2019

  1. AA cost-effectiveness analysis of primary versus hospital-based specialist care for direct acting antiviral hepatitis C treatment,
    Anna Plamer, Amanda Wade; Bridget Draper; Jess Howell; Joseph Doyle; Dennis Petrie; Alexander Thompson; David Wilson; Margaret Hellard; Nick Scott,
    International Journal of Drug Policy, submitted July 2019

  1. Eliminating hepatitis C part 3, Eliminating hepatitis C in General Practice,
    Purcell T, Wade A, Accadia L, Strasser S, Read P, Allard N, Baker D, Pedrana A, Doyle J,
    Medicine Today, August 2019

  1. Outcomes of treatment for hepatitis C in primary care compared to hospital-based care: a randomised controlled trial in people who inject drugs,
    Wade AJ, Doyle JS, Draper B, Iser D, Roberts SK, Kemp W, Petrie D, Scott N, Higgs P, Agius PA, Roney J, Stothers L, Gane E, Stedman C, Thompson AJ, Hellard ME,
    Clinical Infectious Diseases, June 2019.

  1. A randomised controlled trial of community-based provision of direct-acting antiviral therapy for hepatitis C: protocol and challenges,
    Wade AJ, Doyle JS, Draper B, Iser D, Roberts SK, Kemp W, Petrie D, Scott N, Higgs P, Agius, PA, Roney J, Stothers L, Gane E, Stedman C, Thompson AJ, Hellard ME,
    Trials, June 2018.

  1. Disseminated histoplasmosis in a patient with Crohn's disease on dual
    MacIsaac MB, Fehily SR, Muhi S, Yang L, McKelvie PA, Jeremiah CJ, Demediuk, Med J, Aust. 2019 Aug 6. doi: 10.5694/mja2.50298. [Epub ahead of print] No abstract available.
    PMID; 31389018

  1. Rapid micro-organism identification from blood and enrichment fluid cultures using MALDI-TOF mass spectrometry following abbreviated incubation on chocolate agar plates in a high-throughput regional microbiology laboratory.
    Chew R, Otome O, Harris O, Walton A, Hewson D, Luppino M, Cowan RU. Infect Dis (Lond). 2019 Feb 7:1-5. doi: 10.1080/23744235.2019.1565417.

  1. Lessons learned from a randomized controlled trial of short-course intravenous antibiotic therapy for erysipelas and cellulitis of the lower limb (SWITCH Trial).
    Clarke MC, Cheng AC, Pollard JGD, Birch M, Cowan RU, Linke JA, Walton AL, Friedman ND.
    Open Forum Infectious Diseases 2019, ofz335, https://doi.org/10.1093/ofid/ofz335.

2018

  1. Bender J, Chew R, Lin BB, Athan E. Severe Rhabdomyolysis Associated With RSV. Open Forum Infect Dis. 2017 Dec 22;5(1):273. eCollection 2018 Jan.Bender J, Chew R, Lin BB, Athan E. Severe Rhabdomyolysis Associated With RSV. Open Forum Infect Dis. 2017 Dec 22;5(1):273. eCollection 2018 Jan.

  2. Commons RJ, Raby E, Athan E, Bhally H, Chen S, Guy S, Ingram PR, Lai K, Lemoh C, Lim LL, Manning L, Miyakis S, O'Reilly M, Roberts A, Sehu M, Torda A, Vicaretti M, Lazzarini PA. Managing diabetic foot infections: a survey of Australasian infectious diseases clinicians. J Foot Ankle Res. 2018 Apr 10;11:13. eCollection 2018.

  3. Curran D, Oostvogels L, Heineman T, Matthews S, McElhaney J, McNeil S, Diez-Domingo J, Lal H, Andrews C, Athan E, Berglund J, Campora L, de Looze F, Korhonen T, Leung E, Levin M, Volpi A, Johnson RW; ZOE-50/70 study group. Quality of Life impact of a Recombinant Zoster Vaccine in adults ≥50 Years of Age. J Gerontol A Biol Sci Med Sci. 2018 Jun 27. doi: 10.1093/gerona/gly150. [Epub ahead of print]

  4. Flentje K, Knight C, Stromfeldt I, Chakrabarti A, Friedman ND. Recording patient body weight in hospitals: are we doing well enough? Int Med J 2017

  5. Friedman ND, Braun T, Fallach N, Carmeli Y. An analysis of 7 years of blood cultures: epidemiology, microbiology and mortality. Int Med Rev 20176.

  6. Friedman ND, Temkin E, Levit D, Taleb E, Mengesha B, Zaidenstein R, Lazarovitch T, Dadon M, Chen D, Kaye KS, Marchaim D. Towards a Definition for Healthcare-associated Infection. Open Forum Inf Dis, in press 20187.

  7. Heterogeneity in hepatitis C treatment prescribing and uptake in Australia: a geospatial analysis of a year of unrestricted treatment access, Journal of Virus Eradication, 2018; 4: e30–e368.

  8. J Masters P, J Lanfranco P, Sneath E, J Wade A, Huffam S, Pollard J, Standish J, McCloskey K, Athan E, P O'Brien D, Friedman ND. Health issues of refugees attending an infectious disease refugee health clinic in a regional Australian hospital. Aust J Gen Pract. 2018 May;47(5):305-3109.

  9. Koralur M, Singh R, Varma M, Shenoy S, Acharya V, Kamath A, Stenos J, Athan E, Bairy I. Scrub typhus diagnosis on acute specimens using serological and molecular assays - a 3-year prospective study. Diagn Microbiol Infect Dis. 2018 Jun;91(2):112-117. Epub 2018 Feb 24.

  10. Macmorran E, Harch S, Athan E, Lane S, Tong S, Crawford L, Krishnaswamy S, Hewagama S. The rise of methicillin-resistant Staphylococcus aureus: now the dominant cause of skin and soft tissue infection in Central Australia. Epidemiol Infect. 2017 Oct;145(13):2817-2826.

  11. Masters PJ, Miller PJ, Sneath E, Wade AJ, Huffam S, Lim K, Pollard J, Standish J ,McCloskey K, Athan E, O’Brien DP, Friedman ND. Immigrant health service at a regional Australian centre. AFP, 2018, 47(5):305-310

  12. Masters PJ, Miller PJ, Sneath E, Wade AJ, Huffam S, Lim K, Pollard J, Standish J, McCloskey K, Athan E, O’Brien DP, Friedman ND.Immigrant health service at a regional Australian centre Australian family physician, December 2017, in press.

  13. Nick Scott, Joseph S Doyle; David P Wilson; Amanda Wade; Jess Howell; Alisa Pedrana; Alexander Thompson; Margaret E Hellard, Reaching hepatitis C virus elimination targets requires cost-effective health system interventions to enhance the care cascade, Int J Drug Policy, 2017 (47) 107 – 11614.

  14. O'Brien DP. Unlocking of the secrets of Mycobacterium ulcerans disease transmission. Lancet Planet Health. 2017 May;1(2):e52-e53.

  15. O'Brien DP, Athan E, Blasdell K, De Barro P. Tackling the worsening epidemic of Buruli ulcer in Australia in an information void: time for an urgent scientific response. Med J Aust. 2018 Apr 16;208(7):287-289.

  16. O’Brien DP, Friedman ND, Hughes AJ, Walton Al, Athan E. Antibiotic complications during the treatment of Mycobacterium ulcerans disease in Australian patients. Int Med J 2017; 47:1011-1019.

  17. O'Brien DP, Friedman ND, McDonald A, Callan P, Hughes A, Walton A, Athan E. Wound healing: Natural history and risk factors for delay in Australian patients treated with antibiotics for Mycobacterium ulcerans disease. PLoS Negl Trop Dis. 2018 Mar 19;12(3):e0006357. eCollection 2018 Mar.

  18. O’Brien DP, Wynne JW, Buultjens AH, Michalski WP, Stinear TP, Friedman ND, Hughes A, Athan E. Exposure Risk for Infection and Lack of Human-to-Human Transmission of Mycobacterium ulcerans Disease, Australia. Emerging infectious diseases 2017;23(5):837.

  19. O’Donnabhain R, Friedman ND. What makes a good doctor? Int Med J 2018, in press. Study Evaluating the Efficacy and Safety of a Human Monoclonal Antibody, REGN2222, for the Prevention of Medically Attended RSV Infection in Preterm Infants "DAP-PEDBAC-11-02 - A Comparative Evaluation of the Safety and Efficacy of Daptomycin Versus Standard of Care in pediatric Subjects Two - Seventeen Years of Age With Bacteremia caused by Staphylococcus aureus

  20. Pericàs JM, Messina JA, Garcia-de-la-Mària C, Park L, Sharma-Kuinkel BK, Marco F, Wray D, Kanafani ZA, Carugati M, Durante-Mangoni E, Tattevin P, Chu VH, Moreno A, Fowler VG Jr, Miró JM; International Collaboration on Endocarditis Microbiology Investigators. Influence of vancomycin minimum inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus left-sided infective endocarditis treated with ant staphylococcal β-lactam antibiotics: a prospective cohort study by the International Collaboration on Endocarditis. Clin Microbiol Infect. 2017 Aug;23(8):544-549.

  21. Scott N, Hainsworth SW, Sacks-Davis R, Pedrana A, Doyle J, Wade A, Hellard M,

  22. Sethwala A, Wang J, Sturm E, Collins KL, O’Donnabhain R, Friedman ND. Predictive value of symptoms, signs and biomarkers for predicting CTPA results. Int Med J 2017

  23. Sturm E, Tai A, Lin B, Kwong J, Athan E, Howden BP, Angliss RD, Asaid R, Pollard J. Bilateral osteomyelitis and liver abscess caused by hypervirulent Klebsiella pneumoniae- a rare clinical manifestation(case report). BMC Infectious Diseases. 2018: 18:380

  24. Tai AYC, Athan E, Friedman ND, Hughes A, Walton A, O'Brien DP. Increased Severity and Spread of Mycobacterium ulcerans, Southeastern Australia. Emerg Infect Dis. 2018 Jan;24(1). Epub 2018

  25. Wade AJ, Doyle JS, Draper B, Iser D, Roberts SK, Kemp W, Petrie D, Scott N, Higgs P, Agius PA, Roney J, Stothers L, Gane E, Stedman C, Thompson AJ, Hellard ME, A randomised controlled trial of community-based provision of direct-acting antiviral therapy for hepatitis C: protocol and challenges, Trials, accepted June 2018

  26. Wade AJ, McCormack A, Roder C, McDonald K, Davies M, Wardrop M, Athan E, Hellard ME, Aiming for elimination: outcomes of a consultation pathway supporting regional general DEPARTMENT OF INFECTIOUS DISEASES ANNUAL REPORT 1.7.2017 – 30.6.2018Page 39 of 42practitioners to prescribe direct-acting antiviral therapy for hepatitis C, Journal of Viral Hepatitis, April 16, 2018

  27. Wright A, Otome O, Harvey C, Bowe S, Athan E. The Current Epidemiology of Injecting Drug Use-Associated Infective Endocarditis in Victoria, Australia in the Midst of Increasing Crystal Methamphetamine Use. Heart Lung Circ. 2018 Apr;27(4):484-488.

  28. Yeramilli A, Tay E, Stewardson A, Kelley P, Bishop EJ, Jenkin G, Starr M, Trevillyan J, Hughes AJ, Friedman ND, O’Brien DP, Johnson PDR. The location of Australian Buruli ulcer lesions - implications for unravelling disease transmission. PLOS NTD 2017, 11(8):e0005800

2017

Bender J, Chew R, Lin BB, Athan E. Severe Rhabdomyolysis Associated With RSV. Open Forum Infect Dis 2017 Dec 22;5(1):ofx273.

Friedman ND, Carmeli Y, Walton AL, Schwaber MJ. Carbapenem-Resistant Enterobacteriaceae: A Strategic Roadmap for Infection Control. Infect Control Hosp Epidemiol 2017 May;38(5):580-594.

Harch SAJ, MacMorran E, Tong SYC, Holt DC, Wilson J, Athan E, et al. High burden of complicated skin and soft tissue infections in the Indigenous population of Central Australia due to dominant Panton Valentine leucocidin clones ST93-MRSA and CC121-MSSA. BMC Infect Dis 2017 Jun 7;17(1):405-017-2460-3.

Huffam S, Chow EPF, Leeyaphan C, Fairley CK, Hocking JS, Phillips S, et al. Chlamydia Infection Between Men and Women: A Cross-Sectional Study of Heterosexual Partnerships. Open Forum Infect Dis 2017 Sep 27;4(3):ofx160.

Lubel J, Strasser S, Stuart KA, Dore G, Thompson A, Pianko S, et al. Real-world efficacy and safety of ritonavir-boosted paritaprevir, ombitasvir, dasabuvir +/- ribavirin for hepatitis C genotype 1 - final results of the REV1TAL study. Antivir Ther 2017;22(8):699-710.

Macmorran E, Harch S, Athan E, Lane S, Tong S, Crawford L, et al. The rise of methicillin-resistant Staphylococcus aureus: now the dominant cause of skin and soft tissue infection in Central Australia. Epidemiol Infect 2017 Oct;145(13):2817-2826.

Mesic A, Fontaine J, Aye T, Greig J, Thwe TT, Moreto-Planas L, et al. Implications of differentiated care for successful ART scale-up in a concentrated HIV epidemic in Yangon, Myanmar. J Int AIDS Soc 2017 Jul 21;20(Suppl 4):21644.

Miller HM, Tong A, Tunnicliffe DJ, Campbell D, Pinter J, Commons RJ, et al. Identifying and integrating patient and caregiver perspectives for clinical practice guidelines on the screening and management of infectious microorganisms in hemodialysis units. Hemodial Int 2017 Apr;21(2):213-223.

Neels A, Tai A, Devchand F, Athan E. Antimicrobial stewardship in general practice. Medicine Today 2017;18(3):55-58.

O'Brien DP, Friedman D, Hughes A, Walton A, Athan E. Antibiotic complications during the treatment of Mycobacterium ulcerans disease in Australian patients. Intern Med J 2017 Sep;47(9):1011-1019.

O'Brien DP, Wynne JW, Buultjens AH, Michalski WP, Stinear TP, Friedman ND, et al. Exposure Risk for Infection and Lack of Human-to-Human Transmission of Mycobacterium ulcerans Disease, Australia. Emerg Infect Dis 2017 May;23(5):837-840.

O'Brien DP, Wynne JW, Buultjens AH, Michalski WP, Stinear TP, Friedman ND, et al. Exposure Risk for Infection and Lack of Human-to-Human Transmission of Mycobacterium ulcerans Disease, Australia. Emerg Infect Dis 2017 May;23(5):837-840.

Pericas JM, Messina JA, Garcia-de-la-Maria C, Park L, Sharma-Kuinkel BK, Marco F, et al. Influence of vancomycin minimum inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus left-sided infective endocarditis treated with antistaphylococcal beta-lactam antibiotics: a prospective cohort study by the International Collaboration on Endocarditis. Clin Microbiol Infect 2017 Aug;23(8):544-549.

Thurnheer MC, Edwards R, Schulz TR, Yuen L, Littlejohn M, Revill P, et al. Genotypic profiles of hepatitis B in African immigrants and their clinical relevance. J Med Virol 2017 Jun;89(6):1000-1007.

Wade A, Draper B, Doyle J, Allard N, Grinzi P, Thompson A, et al. A survey of hepatitis C management by Victorian GPs after PBS-listing of direct-acting antiviral therapy. Aust Fam Physician 2017;46(4):235-240.

Wright A, Otome O, Harvey C, Bowe S, Athan E. The Current Epidemiology of Injecting Drug Use-Associated Infective Endocarditis in Victoria, Australia in the Midst of Increasing Crystal Methamphetamine Use. Heart Lung Circ 2017 May 9.

2016

Adler A, Friedman ND, Marchaim D. Multidrug-Resistant Gram-Negative Bacilli: Infection Control Implications. Infect Dis Clin North Am 2016 Dec;30(4):967-997.

Blyth CC, Macartney KK, Hewagama S, Senenayake S, Friedman ND, Simpson G, et al. Influenza epidemiology, vaccine coverage and vaccine effectiveness in children admitted to sentinel Australian hospitals in 2014: the Influenza Complications Alert Network (FluCAN). Euro Surveill 2016 Jul 28;21(30):10.2807/1560-7917.ES.2016.21.30.30301.

Bond KA, Vincent G, Wilks CR, Franklin L, Sutton B, Stenos J, et al. One Health approach to controlling a Q fever outbreak on an Australian goat farm. Epidemiol Infect 2016 Apr;144(6):1129-1141.

Cunningham AL, Lal H, Kovac M, Chlibek R, Hwang SJ, Diez-Domingo J, et al. Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older. N Engl J Med 2016 Sep 15;375(11):1019-1032.

Friedman ND, Athan E, Walton AL, O'Brien DP. Increasing Experience with Primary Oral Medical Therapy for Mycobacterium ulcerans Disease in an Australian Cohort. Antimicrob Agents Chemother 2016 Apr 22;60(5):2692-2695.

Friedman ND, Temkin E, Carmeli Y. The negative impact of antibiotic resistance. Clin Microbiol Infect 2016 May;22(5):416-422.

Katz DE, Friedman ND, Ostrovski E, Ravid D, Amrami N, Avivi D, et al. Diabetic foot infection in hospitalized adults. J Infect Chemother 2016 Mar;22(3):167-173.

Kennedy KJ, Daveson K, Slavin MA, van Hal SJ, Sorrell TC, Lee A, et al. Mucormycosis in Australia: contemporary epidemiology and outcomes. Clin Microbiol Infect 2016 Sep;22(9):775-781.

McMahon JH, Spelman T, Ford N, Greig J, Mesic A, Ssonko C, et al. Risk factors for unstructured treatment interruptions and association with survival in low to middle-income countries. AIDS Res Ther 2016 Jul 11;13:25-016-0109-8. eCollection 2016.

Tai A, Heath J, Neels A, Athan E. Infection control in a globalised world: Challenges for general practice. Medicine Today 2016;17(9):37-45.

Trubiano JA, Cheng AC, Korman TM, Roder C, Campbell A, May ML, et al. Australasian Society of Infectious Diseases updated guidelines for the management of Clostridium difficile infection in adults and children in Australia and New Zealand. Intern Med J 2016 Apr;46(4):479-493.

Wade AJ, Veronese V, Hellard ME, Doyle JS. A systematic review of community-based hepatitis C treatment. BMC Infect Dis 2016 May 16;16:202-016-1548-5.

2015

Arnold CJ, Johnson M, Bayer AS, Bradley S, Giannitsioti E, Miro JM, et al. Candida infective endocarditis: an observational cohort study with a focus on therapy. Antimicrob Agents Chemother 2015 Apr;59(4):2365-2373.

Berlon NR, Qi R, Sharma-Kuinkel BK, Joo HS, Park LP, George D, et al. Clinical MRSA isolates from skin and soft tissue infections show increased in vitro production of phenol soluble modulins. J Infect 2015 Oct;71(4):447-457.

Chu VH, Park LP, Athan E, Delahaye F, Freiberger T, Lamas C, et al. Response to Letter Regarding Article, "Association Between Surgical Indications, Operative Risk, and Clinical Outcome in Infective Endocarditis: A Prospective Study From the International Collaboration on Endocarditis". Circulation 2015 Oct 6;132(14):e184-5.

Cowan R, Athan E, Friedman ND, Hughes AJ, McDonald A, Callan P, et al. Mycobacterium ulcerans treatment--can antibiotic duration be reduced in selected patients? PLoS Negl Trop Dis 2015 Feb 6;9(2):e0003503.

Entesari-Tatafi D, Orford N, Athan E. Effectiveness of a care bundle to reduce central line-associated bloodstream infections. Med J Aust 2015 Aug 3;203(3):138.

Ford N, Shubber Z, Meintjes G, Grinsztejn B, Eholie S, Mills EJ, et al. Causes of hospital admission among people living with HIV worldwide: a systematic review and meta-analysis. Lancet HIV 2015 Oct;2(10):e438-44.

Harris PN, Peleg AY, Iredell J, Ingram PR, Miyakis S, Stewardson AJ, et al. Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trial. Trials 2015 Jan 27;16:24-014-0541-9.

Huffam S, Chow EP, Fairley CK, Hocking J, Peel J, Chen M. Chlamydia infection in individuals reporting contact with sexual partners with chlamydia: a cross-sectional study of sexual health clinic attendees. Sex Transm Infect 2015 Sep;91(6):434-439.

Lal H, Cunningham AL, Godeaux O, Chlibek R, Diez-Domingo J, Hwang SJ, et al. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med 2015 May 28;372(22):2087-2096.

O'Brien DP, Friedman ND, Cowan R, Pollard J, McDonald A, Callan P, et al. Mycobacterium ulcerans in the Elderly: More Severe Disease and Suboptimal Outcomes. PLoS Negl Trop Dis 2015 Dec 2;9(12):e0004253.

O'Brien DP, Huffam S. Pre-emptive steroids for a severe oedematous Buruli ulcer lesion: a case report. J Med Case Rep 2015 May 1;9:98-015-0584-x.

Rogers BA, Ingram PR, Runnegar N, Pitman MC, Freeman JT, Athan E, et al. Sequence type 131 fimH30 and fimH41 subclones amongst Escherichia coli isolates in Australia and New Zealand. Int J Antimicrob Agents 2015 Apr;45(4):351-358.

Slavin M, van Hal S, Sorrell TC, Lee A, Marriott DJ, Daveson K, et al. Invasive infections due to filamentous fungi other than Aspergillus: epidemiology and determinants of mortality. Clin Microbiol Infect 2015 May;21(5):490.e1-490.10.

Stuart RL, Marshall C, Orr E, Bennett N, Athan E, Friedman D, et al. Survey of infection control and antimicrobial stewardship practices in Australian residential aged-care facilities. Intern Med J 2015 May;45(5):576-580.

Tung MK, Light M, Giri R, Lane S, Appelbe A, Harvey C, et al. Evolving epidemiology of injecting drug use-associated infective endocarditis: A regional centre experience. Drug Alcohol Rev 2015 Jul;34(4):412-417.

Wade AJ, Macdonald DM, Doyle JS, Gordon A, Roberts SK, Thompson AJ, et al. The Cascade of Care for an Australian Community-Based Hepatitis C Treatment Service. PLoS One 2015 Nov 12;10(11):e0142770.

Last Modified: Thursday, 25 January 2024

Related Links

Infectious Diseases and Refugee Health Clinic